New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
09:04 EDTBCLIBrainStorm Cell receives notice from EPO to grant patent
BrainStorm Cell Therapeutics announced that it has received notification from the European Patent Office of its intention to grant the company’s patent application No. EP06766101.7. This patent relates to the method of production of the company's proprietary stem cells induced to secrete large quantities of neurotrophic factors for the treatment of neurodegenerative diseases. The company's proprietary NurOwn stem cell therapy was developed from this differentiation method.
News For BCLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
06:48 EDTBCLIBrainStorm receives $1.1M from Israel's OCS
BrainStorm Cell Therapeutics announced today that wholly-owned subsidiary Brainstorm Cell Therapeutics was awarded a grant of approximately $1.1M from Israel's Office of the Chief Scientist, or OCS. This is the eighth year that BrainStorm has been in receipt of grant support from the Office of the Chief Scientist, which is part of the Ministry of Trade and Industry Program to support innovative technologies in Israel. The funds will support the development NurOwn, BrainStorm's innovative mesenchymal stem cell-based platform for treating neurodegenerative diseases including BrainStorm's phase 2 clinical program in amyotrophic lateral sclerosis.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use